Yunxiang Ji

32 items found for "Yunxiang Ji"

Posts (9)

Trevena Announce Submission of New Drug Application in China for OLINVYK® by its Partner Jiangsu ...
February 2022 Trevena Announces Submission of New Drug Application in China for OLINVYK® by its Partner Jiangsu The NDA was submitted by Trevena’s partner, Jiangsu Nhwa Pharmaceutical, and follows completion by Nhwa
Transmembrane domains of GPCR dimers – a novel hot spot for drug discovery
Ji, et al. 2020; L. Wan, 2020). Ji et al., 2020).
Exploring the Breakthroughs in GPCR Research
guide to heterotrimeric G protein activity biosensors Marta Lopez-Balastegui , Antonella Di Pizio , Jiafei

G Protein-coupled Receptor-mediated Membrane Targeting of PLCγ2 is Essential for Neutrophil Chemotaxis
chemotaxis. " Authors Xuehua Xu , Xi Wen , Smit Bhimani , Amer Moosa , Dustin Parsons , HyunGee Ha , Tian Ji
Prediction of survival and immunotherapy response by the combined classifier of G protein-coupled receptors and tumor microenvironment in melanoma
Qiangcheng Wang , Lu Wang , Yang Yang , Min Ren , Yanlin Li , Zixu Gao , Shaoluan Zheng , Yiteng Ding , Jiani Ji , Chenlu Wei , Tianyi Zhang , Yu Zhu , Jia Feng , Feng Qin , Yanwen Yang , Chuanyuan Wei , Jianying
Elucidation of active components and target mechanism in Jinqiancao granules for the treatment of prostatitis and benign prostatic hyperplasia
GPCR News < GPCRs in Oncology and Immunology Elucidation of active components and target mechanism in Jinqiancao Jinqiancao granules are a traditional Chinese medicine used to treat kidney stones and this medicine Aim of the study: We hypothesized that Jinqiancao granules could be a potential therapy for prostatitis Materials and methods: Jinqiancao granules were commercially available and purchased. An experiment-based network reflected a pharmacological relationship between Jinqiancao granules and